NDC 78206-171

SINGULAIR

Montelukast Sodium

SINGULAIR is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Organon Llc. The primary component is Montelukast Sodium.

• Product ID: 78206-171_44fce13e-2484-4ea6-9995-2e2b68331c29
• NDC: 78206-171
• Product Type: Human Prescription Drug
• Proprietary Name: SINGULAIR
• Generic Name: Montelukast Sodium
• Dosage Form: Granule
• Route of Administration: ORAL
• Marketing Start Date: 2021-06-01
• Marketing Category: NDA /
• Application Number: NDA021409
• Labeler Name: Organon LLC
• Substance Name: MONTELUKAST SODIUM
• Active Ingredient Strength: 4 mg/1
• Pharm Classes: Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 78206-171-01

30 PACKET in 1 CARTON (78206-171-01) > 1 GRANULE in 1 PACKET

• Marketing Start Date: 2021-06-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "SINGULAIR" or generic name "Montelukast Sodium"

NDC	Brand Name	Generic Name
0006-1711	SINGULAIR	montelukast sodium
0006-3841	SINGULAIR	montelukast sodium
0006-9117	SINGULAIR	montelukast sodium
0006-9275	SINGULAIR	montelukast sodium
68258-3033	SINGULAIR	SINGULAIR
68258-3032	SINGULAIR	SINGULAIR
21695-221	SINGULAIR	SINGULAIR
21695-565	SINGULAIR	SINGULAIR
63629-2979	SINGULAIR	SINGULAIR
63629-3701	SINGULAIR	SINGULAIR
0054-0259	Montelukast Sodium	Montelukast Sodium
0054-0288	Montelukast Sodium	Montelukast Sodium
0054-0289	Montelukast Sodium	Montelukast Sodium
0093-7424	Montelukast Sodium	Montelukast Sodium
0093-7425	Montelukast Sodium	Montelukast Sodium